FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Unity Subcutaneous Infusion System for Remodulin
K Number: K191313
·
Decision Feb 21, 2020
Classifications
1
FEI Numbers
7
Registration Numbers
7
Same Product Code
3
Applicant Total
3
Review Days
282
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Unity Subcutaneous Infusion System for Remodulin
- K Number
- K191313
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 880.5725
- Medical Specialty
- General Hospital
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- DEKA Research & Development
- Date Received
- May 15, 2019
- Decision Date
- February 21, 2020
- Product Code
- QJY
- Advisory Committee
- General Hospital
- Review Advisory Committee
- HO
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| QJY | Infusion Pump, Drug Specific, Pharmacy-Filled | FDA class 2 | General Hospital |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (QJY), ordered by most recent decision date.
Remunity System
FDA 510(k)
FDA Class 2
·General Hospital
Remunity System
FDA 510(k)
FDA Class 2
·General Hospital
Remunity Pump for Remodulin (treprostinil) Injection
FDA 510(k)
FDA Class 2
·General Hospital